EC Healthcare (UNHLF)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
EC Healthcare (UNHLF) trades at $0.09. EC Healthcare is an investment holding company providing medical and healthcare services across Hong Kong, Macau, and mainland China. Market cap: $101.07M, Sector: Consumer defensive.
Last analyzed: Mar 16, 2026Analyst Coverage for UNHLF: UNHLF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates UNHLF against Consumer Defensive peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
UNHLF: 1/1 perspectives are bearish.
EC Healthcare (UNHLF) Consumer Business Overview
EC Healthcare operates as a diversified medical and wellness service provider in Hong Kong, Macau, and mainland China, offering aesthetic medical, dental, and general healthcare services. With a focus on private-label brands, the company caters to a broad consumer base seeking comprehensive health and beauty solutions.
What Is the Investment Thesis for UNHLF?
EC Healthcare presents a mixed investment profile. While the company boasts a high gross margin of 74.8%, its negative profit margin of -4.8% and negative P/E ratio of -3.15 raise concerns about profitability. Growth catalysts include expansion within the Chinese market and further development of its private-label brands. However, potential risks include the competitive landscape in the healthcare sector and the company's current lack of profitability. Investors should closely monitor EC Healthcare's ability to improve its financial performance and capitalize on growth opportunities in the coming years.
Based on FMP financials and quantitative analysis
UNHLF Key Highlights
- EC Healthcare operates in three segments: Medical, Aesthetic Medical and Beauty and Wellness, and Others, providing diversified revenue streams.
- The company's gross margin stands at 74.8%, indicating strong pricing power and efficient cost management in its service offerings.
- EC Healthcare has a market capitalization of $0.10 billion, reflecting its current valuation in the OTC market.
- The company employs 2,872 individuals, demonstrating a significant operational scale in the healthcare services industry.
- EC Healthcare's beta of 1.20 suggests higher volatility compared to the market, potentially offering higher returns but also increased risk.
Who Are UNHLF's Competitors?
UNHLF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| BUBSF Bubs Australia Limited | $0.08 | +0.00% | $69.21M | 53 |
| CVNZF Comvita Limited | $0.42 | +0.00% | $30.05M | 41 |
| CWGL Crimson Wine Group, Ltd. | $4.35 | +0.00% | $89.55M | 43 |
| GBCMY Global Bio-chem Technology Group Company Limited | $0.41 | +0.00% | $73.88M | 46 |
| KPTSF KP Tissue Inc. | $9.31 | -0.11% | $93.31M | 48 |
| FACYF Fancl Corporation | $17.45 | +0.00% | $2.37B | 63 |
| SGI Somnigroup International Inc | $72.67 | +0.48% | $15.28B | 62 |
| ELF e.l.f. Beauty, Inc. | $60.68 | +4.40% | $3.61B | 59 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are UNHLF's Key Strengths?
- Diversified service offerings across medical and aesthetic fields.
- Established presence in Hong Kong, Macau, and mainland China.
- Private-label brands providing a degree of differentiation.
- Integrated service model covering various healthcare needs.
What Are UNHLF's Weaknesses?
- Negative profit margin and P/E ratio.
- Reliance on specific geographic markets.
- Potential brand awareness limitations compared to larger competitors.
- Exposure to regulatory changes in the healthcare sector.
What Could Drive UNHLF Stock Higher?
- Expansion into new geographic markets within mainland China, leveraging the growing demand for healthcare services.
- Development and promotion of private-label brands to increase brand recognition and customer loyalty.
- Strategic partnerships and acquisitions to broaden service offerings and market reach.
- Implementation of digital platforms and e-commerce channels to enhance customer engagement.
- Focus on high-margin services, such as aesthetic medical treatments, to improve overall profitability.
What Are the Key Risks for UNHLF?
- Intense competition in the healthcare and beauty industries may limit market share and pricing power.
- Economic downturns could reduce consumer spending on discretionary services, impacting revenue.
- Regulatory changes in the healthcare sector could increase compliance costs and operational challenges.
- Fluctuations in currency exchange rates could affect financial performance.
- Negative profit margin and P/E ratio indicate financial instability and potential difficulty in attracting investors.
What Are the Growth Opportunities for UNHLF?
- Expansion in Mainland China: EC Healthcare has a significant opportunity to expand its presence in mainland China, capitalizing on the increasing demand for medical and aesthetic services. The Chinese market's large population and growing disposable incomes present a substantial growth avenue. Successful expansion could significantly boost revenue and market share over the next 3-5 years.
- Development of Private-Label Brands: The company's private-label brands, such as PRODERMA LAB and Swissline, offer a strong growth opportunity. By further developing and marketing these brands, EC Healthcare can increase its brand recognition and customer loyalty. This strategy can lead to higher margins and a more sustainable competitive advantage within the next 2-3 years.
- Strategic Partnerships and Acquisitions: EC Healthcare can pursue strategic partnerships and acquisitions to expand its service offerings and geographic reach. Collaborating with other healthcare providers or acquiring complementary businesses can enhance the company's capabilities and market position. These initiatives could yield significant benefits within the next 1-2 years.
- Digitalization and E-commerce: Investing in digital platforms and e-commerce channels can improve customer engagement and accessibility. By offering online consultations, appointment booking, and product sales, EC Healthcare can attract a broader customer base and enhance the overall customer experience. This digital transformation can drive growth within the next 1-3 years.
- Focus on High-Margin Services: EC Healthcare can prioritize high-margin services, such as aesthetic medical treatments and specialized medical procedures, to improve its overall profitability. By focusing on these services, the company can optimize its revenue mix and enhance its financial performance. This strategy can lead to improved profit margins within the next 1-2 years.
What Opportunities Does UNHLF Have?
- Expansion in mainland China's growing healthcare market.
- Development and marketing of private-label brands.
- Strategic partnerships and acquisitions to expand service offerings.
- Digitalization and e-commerce initiatives to improve customer engagement.
What Threats Does UNHLF Face?
- Intense competition in the healthcare and beauty industries.
- Economic downturns affecting consumer spending on discretionary services.
- Regulatory changes impacting healthcare service delivery.
- Fluctuations in currency exchange rates affecting financial performance.
What Are UNHLF's Competitive Advantages?
- Established presence in Hong Kong, Macau, and mainland China.
- Diversified service offerings across medical and aesthetic fields.
- Private-label brands providing a degree of differentiation.
- Integrated service model covering various healthcare needs.
What Does UNHLF Do?
Founded in 2005 and headquartered in Mong Kok, Hong Kong, EC Healthcare has evolved into a comprehensive medical and healthcare service provider. Originally known as Union Medical Healthcare Limited, the company rebranded to EC Healthcare in April 2021 to reflect its expanded service offerings. The company operates through three primary segments: Medical, Aesthetic Medical and Beauty and Wellness, and Others. These segments encompass a wide array of services, including quasi-medical treatments, beauty and wellness services, medical imaging, medical and aesthetic surgeries, dental care, hair treatments, vaccinations, chiropractic services, psychological counseling, and orthopedics. EC Healthcare also provides administrative and management support, laboratory testing, performance marketing, and travel agency services. The company further engages in the sale of beauty and skincare products under its private-label brands, such as PRODERMA LAB, Swissline, Suissebeaute, and re:HEALTH. Additionally, EC Healthcare invests in healthcare machines and property, and offers multi-channel networking and veterinary services, solidifying its position as a diversified healthcare provider in the region.
What Products and Services Does UNHLF Offer?
- Provides medical and healthcare services in Hong Kong, Macau, and the People's Republic of China.
- Offers quasi-medical, beauty and wellness services.
- Conducts medical imaging and medical surgeries.
- Provides aesthetic medical beauty and dental services.
- Offers hair treatment, vaccine, chiropractic, psychological, and orthopedics services.
- Sells beauty and skincare products under private-label brands.
- Operates in healthcare machines and property investment holding businesses.
- Provides multi-channel networking and related services, and veterinary services.
How Does UNHLF Make Money?
- Generates revenue through medical and healthcare service fees.
- Sells beauty and skincare products under its private-label brands.
- Provides administrative and management support services.
- Operates in healthcare machines and property investment holding businesses.
What Industry Does UNHLF Operate In?
EC Healthcare operates within the consumer defensive sector, specifically in the household and personal products industry, which includes medical and healthcare services. The industry is characterized by increasing demand for aesthetic and medical treatments, particularly in Asia. EC Healthcare competes with other healthcare providers and beauty service companies. The company's focus on private-label brands and diverse service offerings positions it to capture a segment of this growing market. However, competition remains intense, requiring continuous innovation and effective marketing strategies.
Who Are UNHLF's Key Customers?
- Individuals seeking medical and healthcare services.
- Customers interested in beauty and wellness treatments.
- Patients requiring dental and orthopedic care.
- Consumers purchasing beauty and skincare products.
UNHLF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
UNHLF Latest News
No recent news available for UNHLF.
UNHLF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for UNHLF.
Price Targets
Wall Street price target analysis for UNHLF.
UNHLF MoonshotScore
What does this score mean?
The MoonshotScore rates UNHLF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Lyn Wade Lu
CEO
Lyn Wade Lu serves as the CEO of EC Healthcare, managing a workforce of 2,872 employees. Information regarding Lyn Wade Lu's detailed career history, education, and previous roles is not available in the provided data. Further research would be required to provide a comprehensive background.
Track Record: Due to limited information, specific achievements and strategic decisions made by Lyn Wade Lu during their tenure as CEO are unknown. Further research is needed to evaluate their track record and contributions to EC Healthcare's milestones.
UNHLF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that EC Healthcare may not meet the minimum financial standards or disclosure requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial reporting or may not be current in their filings. Investing in companies on the OTC Other tier carries higher risks due to the lack of regulatory oversight and transparency compared to stocks listed on major exchanges like the NYSE or NASDAQ.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure and transparency.
- Higher price volatility due to lower trading volumes.
- Potential for fraud or manipulation due to less regulatory oversight.
- Difficulty in obtaining accurate and timely information about the company.
- Risk of delisting or suspension from the OTC market.
- Verify the company's financial statements and SEC filings (if any).
- Research the company's management team and their track record.
- Assess the company's business model and competitive landscape.
- Evaluate the company's legal and regulatory compliance.
- Check for any red flags or warning signs, such as pending lawsuits or regulatory investigations.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor before making any investment decisions.
- Longevity of operations since its founding in 2005.
- Presence in multiple geographic locations (Hong Kong, Macau, and mainland China).
- Diversified service offerings across medical and aesthetic fields.
- Employment of a substantial workforce (2,872 employees).
- Existence of private-label brands (PRODERMA LAB, Swissline, Suissebeaute, and re:HEALTH).
EC Healthcare Consumer Defensive Stock: Key Questions Answered
What does EC Healthcare do?
EC Healthcare operates as an investment holding company, primarily focused on providing a diverse range of medical and healthcare services. These services span across medical treatments, aesthetic medical procedures, beauty and wellness services, dental care, and other related offerings. The company caters to customers in Hong Kong, Macau, and mainland China, leveraging its private-label brands and integrated service model to address various healthcare and aesthetic needs. The company's business model revolves around generating revenue through service fees and product sales within the healthcare and beauty sectors.
What are the main risks for UNHLF?
EC Healthcare faces several key risks. Intense competition in the healthcare and beauty industries could limit its market share and pricing power. Economic downturns may reduce consumer spending on discretionary services, impacting revenue. Regulatory changes in the healthcare sector could increase compliance costs and operational challenges. Fluctuations in currency exchange rates could affect financial performance. The company's negative profit margin and P/E ratio also pose significant financial risks, indicating potential difficulty in achieving profitability and attracting investors.
What are the key factors to evaluate for UNHLF?
Evaluate UNHLF on fundamentals, analyst consensus, and risk factors. Not financial advice.
How frequently does UNHLF data refresh on this page?
UNHLF prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven UNHLF's recent stock price performance?
EC Healthcare (UNHLF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diversified service offerings across medical and aesthetic fields. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider UNHLF overvalued or undervalued right now?
Valuing EC Healthcare (UNHLF) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying UNHLF?
Before investing in EC Healthcare (UNHLF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding UNHLF to a portfolio?
Key strength of EC Healthcare (UNHLF): Diversified service offerings across medical and aesthetic fields. Weigh rewards against risks and diversify. Not financial advice.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available for CEO background and track record.
- OTC market data may have limited reliability compared to major exchanges.
- AI analysis pending for UNHLF stock.